Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product
Status:
Completed
Trial end date:
2020-01-28
Target enrollment:
Participant gender:
Summary
This Pivotal study investigated the bioavailability in women of 2 tablet formulations
containing Desogestrel 0.075 mg. The Pivotal study was performed at a single site with 30
subjects. Participants took 2 tablets of the test product and reference product in 2 periods
and 2 sequences (either test after reference or reference after test). There was a washout of
14 days between each study period.